Clinical Trial Update: Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

View source ↗

Summary

Real-world study evaluating the effectiveness of TezepeLumaB in patients with severe asthma across phenotypes in Russia; the study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: ACTIVE_NOT_RECRUITING